Group One Trading’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Group One Trading’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,500	Closed	-$57.6K	–	8281
2023 Q4	$57.6K	Buy	3,500 +2,000	+133%	+$31.5K	﹤0.01%	4941
2023 Q3	$11.6K	Sell	1,500 -3,500	-70%	-$19K	﹤0.01%	6261
2023 Q2	$25.9K	Buy	+5,000	New	+$25.5K	﹤0.01%	5788
2022 Q1	–	Sell	-7,130	Closed	-$94K	–	8948
2021 Q4	$94K	Sell	7,130 -13,050	-65%	-$216K	﹤0.01%	5787
2021 Q3	$464K	Buy	20,180 +12,360	+158%	+$368K	﹤0.01%	4280
2021 Q2	$343K	Buy	7,820 +190	+2%	+$10.6K	﹤0.01%	4638
2021 Q1	$554K	Sell	7,630 -2,640	-26%	-$188K	﹤0.01%	3916
2020 Q4	$444K	Buy	+10,270	New	+$460K	﹤0.01%	3369

Group One Trading's ORTX Position: Q1 2024 in Review

Group One Trading sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 1,197 shares — an estimated $19.7K sold.

Group One Trading first reported a position in ORTX in Q3 2020 and held it in 9 quarters. The position peaked at $452K in Q1 2021. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.

Group One Trading reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Group One Trading sold 1,197 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $19.7K.
Group One Trading first reported a position in Orchard Therapeutics plc American Depositary Shares in Q3 2020 and held it in 9 quarters.
Group One Trading's Orchard Therapeutics plc American Depositary Shares position peaked at $452K in Q1 2021.
0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.

Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.